FDA guidelines to help personalized drug development

As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!